Gregory P. Bisson

3.6k total citations · 1 hit paper
70 papers, 1.9k citations indexed

About

Gregory P. Bisson is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Gregory P. Bisson has authored 70 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Infectious Diseases, 37 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in Gregory P. Bisson's work include Tuberculosis Research and Epidemiology (30 papers), Pneumocystis jirovecii pneumonia detection and treatment (24 papers) and HIV/AIDS drug development and treatment (18 papers). Gregory P. Bisson is often cited by papers focused on Tuberculosis Research and Epidemiology (30 papers), Pneumocystis jirovecii pneumonia detection and treatment (24 papers) and HIV/AIDS drug development and treatment (18 papers). Gregory P. Bisson collaborates with scholars based in United States, Botswana and South Africa. Gregory P. Bisson's co-authors include Drew Weissman, Shruthi Ravimohan, Hardy Kornfeld, Robert Gross, Scarlett L. Bellamy, Ian Frank, Andrew P. Steenhoff, Tendani Gaolathe, Mina C. Hosseinipour and Amita Gupta and has published in prestigious journals such as The Lancet, Blood and PLoS ONE.

In The Last Decade

Gregory P. Bisson

66 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tuberculosis and lung damage: from epidemiology to pathophysiology

2018 322 citations Shruthi Ravimohan, Hardy Kornfeld et al. European Respiratory Review profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregory P. Bisson United States	23	1.4k	1000	352	317	188	70	1.9k
Juan Sierra‐Madero Mexico	27	1.0k 0.8×	1.0k 1.0×	506 1.4×	215 0.7×	308 1.6×	116	2.3k
Ebrahim Variava South Africa	26	1.4k 1.0×	1.8k 1.8×	93 0.3×	337 1.1×	109 0.6×	113	2.4k
Christoph D. Spinner Germany	20	1.0k 0.7×	673 0.7×	257 0.7×	123 0.4×	140 0.7×	127	1.8k
Peter Kim United States	17	1.3k 0.9×	758 0.8×	306 0.9×	327 1.0×	134 0.7×	29	1.7k
Muriel Vray France	26	852 0.6×	799 0.8×	573 1.6×	156 0.5×	47 0.3×	96	2.2k
Katsuji Teruya Japan	23	999 0.7×	773 0.8×	316 0.9×	146 0.5×	325 1.7×	116	1.8k
Alexia Cusini Switzerland	21	536 0.4×	578 0.6×	258 0.7×	141 0.4×	188 1.0×	42	1.3k
Elizabeth C. George United Kingdom	17	816 0.6×	694 0.7×	139 0.4×	318 1.0×	166 0.9×	44	1.4k
Alice K. Pau United States	20	1.5k 1.1×	1.4k 1.4×	632 1.8×	317 1.0×	249 1.3×	60	2.7k
Debbie Marriott Australia	18	572 0.4×	494 0.5×	160 0.5×	170 0.5×	112 0.6×	38	1.3k

Countries citing papers authored by Gregory P. Bisson

Since Specialization

Citations

This map shows the geographic impact of Gregory P. Bisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory P. Bisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory P. Bisson more than expected).

Fields of papers citing papers by Gregory P. Bisson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory P. Bisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory P. Bisson. The network helps show where Gregory P. Bisson may publish in the future.

Co-authorship network of co-authors of Gregory P. Bisson

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory P. Bisson. A scholar is included among the top collaborators of Gregory P. Bisson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory P. Bisson. Gregory P. Bisson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Auld, Sara C., Artur T. L. Queiroz, Mariana Araújo‐Pereira, et al.. (2025). Inflammatory profiles in sputum and blood of people with TB with and without HIV coinfection. Tuberculosis. 151. 102612–102612.

Larson, Peter S., et al.. (2025). The impact of COVID-19 and public health measures on homicide and suicide trends in Botswana using an interrupted time series analysis. Injury Epidemiology. 12(1). 42–42.

Maenetje, Pholo, Diana B. Schramm, Robert S. Wallis, et al.. (2023). Circulating Biomarkers, Fraction of Exhaled Nitric Oxide, and Lung Function in Patients With Human Immunodeficiency Virus and Tuberculosis. The Journal of Infectious Diseases. 229(3). 824–832. 1 indexed citations

Queiroz, Artur T. L., Amita Gupta, Nikhil Gupte, et al.. (2021). Integrative Multi-Omics Reveals Serum Markers of Tuberculosis in Advanced HIV. Frontiers in Immunology. 12. 676980–676980. 10 indexed citations

Ravimohan, Shruthi, Hardy Kornfeld, Drew Weissman, & Gregory P. Bisson. (2018). Tuberculosis and lung damage: from epidemiology to pathophysiology. European Respiratory Review. 27(147). 170077–170077. 322 indexed citations breakdown →

Vujković, Marijana, Scarlett L. Bellamy, Athena F. Zuppa, et al.. (2018). Polymorphisms in cytochrome P450 are associated with extensive efavirenz pharmacokinetics and CNS toxicities in an HIV cohort in Botswana. The Pharmacogenomics Journal. 18(5). 678–688. 14 indexed citations

Ravimohan, Shruthi, Houping Ni, Andrew P. Steenhoff, et al.. (2017). Elevated Pre–Antiretroviral Therapy CD39+CD8+ T Cell Frequency Is Associated With Early Mortality in Advanced Human Immunodeficiency Virus/Tuberculosis Co-infection. Clinical Infectious Diseases. 64(10). 1453–1456. 7 indexed citations

Zentner, Isaac, Chawangwa Modongo, Nicola M. Zetola, et al.. (2017). Urine colorimetry for therapeutic drug monitoring of pyrazinamide during tuberculosis treatment. International Journal of Infectious Diseases. 68. 18–23. 11 indexed citations

Vinnard, Christopher, Shruthi Ravimohan, Jotam G. Pasipanodya, et al.. (2017). Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation. PLoS ONE. 12(11). e0187624–e0187624. 11 indexed citations

10.

Gross, Robert, Scarlett L. Bellamy, Xiaoyan Han, et al.. (2016). Effects of sex and alcohol use on antiretroviral therapy outcomes in Botswana: a cohort study. Addiction. 112(1). 73–81. 12 indexed citations

11.

Ravimohan, Shruthi, Andrew P. Steenhoff, Ian Frank, et al.. (2015). Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4⁺T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome. Clinical Infectious Diseases. 62(6). 795–803. 31 indexed citations

12.

Bisson, Gregory P., Nicola M. Zetola, & Ronald G. Collman. (2015). Persistent High Mortality in Advanced HIV/TB Despite Appropriate Antiretroviral and Antitubercular Therapy: an Emerging Challenge. Current HIV/AIDS Reports. 12(1). 107–116. 20 indexed citations

13.

Zetola, Nicola M., Chawangwa Modongo, Patrick K. Moonan, et al.. (2014). Clinical Outcomes Among Persons With Pulmonary Tuberculosis Caused by Mycobacterium tuberculosis Isolates With Phenotypic Heterogeneity in Results of Drug-Susceptibility Tests. The Journal of Infectious Diseases. 209(11). 1754–1763. 40 indexed citations

14.

Ravimohan, Shruthi, Andrew P. Steenhoff, Ann Tierney, et al.. (2013). Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis. The Journal of Infectious Diseases. 208(11). 1784–1793. 24 indexed citations

15.

Vinnard, Christopher, E. Paul Wileyto, Gregory P. Bisson, & Carla A. Winston. (2013). First Use of Multiple Imputation with the National Tuberculosis Surveillance System. PubMed. 2013. 1–6. 4 indexed citations

16.

Steele, Katherine T., et al.. (2010). In-hospital mortality of HIV-infected cryptococcal meningitis patients withC. gattiiandC. neoformansinfection in Gaborone, Botswana. Medical Mycology. 48(8). 1112–1115. 35 indexed citations

17.

Bisson, Gregory P., et al.. (2008). Antiretroviral Failure Despite High Levels of Adherence: Discordant Adherence-Response Relationship in Botswana. JAIDS Journal of Acquired Immune Deficiency Syndromes. 49(1). 107–110. 38 indexed citations

18.

Bisson, Gregory P., Rameshwari Thakur, Pablo Tebas, et al.. (2008). The Use of HAART Is Associated With Decreased Risk of Death During Initial Treatment of Cryptococcal Meningitis in Adults in Botswana. JAIDS Journal of Acquired Immune Deficiency Syndromes. 49(2). 227–229. 34 indexed citations

19.

Bisson, Gregory P., Ian Frank, Robert Gross, et al.. (2006). Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector. AIDS. 20(9). 1333–1336. 27 indexed citations

20.

Bisson, Gregory P., Brian L. Strom, Robert Gross, et al.. (2005). Effect of GB virus C viremia on HIV acquisition and HIV set-point. AIDS. 19(16). 1910–1912. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact